Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non-Small-Cell Lung Cancer Related to Wood-Smoke Exposure

被引:53
作者
Arrieta, Oscar [1 ,2 ,3 ]
Campos-Parra, Alma D. [2 ]
Zuloaga, Carlos [1 ]
Aviles, Alejandro [4 ]
Sanchez-Reyes, Roberto [2 ]
Vazquez Manriquez, Maria Eugenia [5 ]
Covian-Molina, Emilia [1 ]
Martinez-Barrera, Luis
Meneses, Abelardo [6 ]
Cardona, Andres [7 ]
Borbolla-Escoboza, Jose R. [8 ]
机构
[1] Inst Nacl Cancerol, Clin Oncol Torac, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Expt Oncol Lab, Mexico City 14080, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico
[4] Inst Nacl Cancerol, Dept Patol, Mexico City 14080, DF, Mexico
[5] INER, Dept Patol, Mexico City, DF, Mexico
[6] Inst Nacl Cancerol, Lab Med Traslac, Mexico City, DF, Mexico
[7] Fdn Santa Fe Bogota, Inst Oncol, Clin & Traslat Oncol Grp, Bogota, Colombia
[8] Boehringer Ingelheim GmbH & Co KG, Mexico City, DF, Mexico
关键词
NSCLC; Wood-smoke exposure; Outcome; Mutational profiles; GROWTH-FACTOR RECEPTOR; TOBACCO-SMOKE; NEVER SMOKERS; OPEN-LABEL; GENE; ADENOCARCINOMA; GEFITINIB; SURVIVAL; TP53; ASSOCIATION;
D O I
10.1097/JTO.0b013e3182582a93
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypothesis: Although smoking is the major risk factor for non-small-cell lung cancer (NSCLC), other factors are also associated with lung carcinogenesis, such as wood-smoke exposure (WSE). This article has been aimed at suggesting that lung cancer related to cigarette smoking and lung cancer related to WSE have different clinical and genetic characteristics. Experimental Design: A cohort of 914 lung cancer patients was prospectively studied; they had been treated at Mexico's National Cancer Institute between 2007 and 2010. The associations of WSE and cigarette smoking with clinical characteristics, mutation profile, response to chemotherapy, and epidermal growth factor receptor tyrosine kinase inhibitors were analyzed, and overall survival (OS) rate was calculated. The trial was registered with ClinicalTrials.gov: NCT01023828. Results: Of the lung cancer patients studied, 95.1% were classified as coming within the NSCLC histology subtype; 58% of the patients smoked cigarettes, 35% had a background of WSE (exposure to both cigarette smoke and wood smoke was documented in 12.1% of all patients), and 19.4% patients had no smoke-exposure background. WSE was associated with NSCLC and adenocarcinoma histology, and was also more frequently associated with epidermal growth factor receptor-mutations than cigarette-smoking patients were (50.0% cf. 19.4%), whereas KRAS mutations were less common in WSE patients (6.7%) than in smokers (21%). WSE patients had a higher epidermal growth factor receptor tyrosine kinase inhibitor response rate (39.7%) than smokers (18.8%). The NSCLC patient WSE group's OS was longer (22.7 months) than that for smokers (13.8 months). Conclusion: NSCLC patients who smoked tobacco/cigarettes differed from those having a background of WSE regarding tumor histology, mutation profile, response rate, and OS, indicating that different carcinogenic mechanisms were induced by these two types of smoke exposure.
引用
收藏
页码:1228 / 1234
页数:7
相关论文
共 37 条
[1]  
AKIBA S, 1986, CANCER RES, V46, P4804
[2]   CHRONIC LUNG-DISEASE IN THE PAPUA-NEW-GUINEA HIGHLANDS [J].
ANDERSON, HR .
THORAX, 1979, 34 (05) :647-653
[3]   Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients - An open lobel phase II study [J].
Arrieta, Oscar ;
Martinez-Barrera, Luis ;
Trevino, Sergio ;
Guzman, Enrique ;
Castillo-Gonzalez, Patricia ;
Angel Rios-Trejo, Miguel ;
Flores-Estrada, Diana ;
Tellez, Eduardo ;
Gonzalez, Cesar ;
de la Cruz Vargas, Johny ;
Gonzalez-De la Rosa, Claudia Haydee ;
Hernandez-Pedro, Norma ;
Morales-Barrera, Rafael ;
De la Garza, Jaime .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) :887-893
[4]   Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America [J].
Arrieta, Oscar ;
Felipe Cardona, Andres ;
Federico Bramuglia, Guillermo ;
Gallo, Aly ;
Campos-Parra, Alma D. ;
Serrano, Silvia ;
Castro, Marcelo ;
Aviles, Alejandro ;
Amorin, Edgar ;
Kirchuk, Ricardo ;
Cuello, Mauricio ;
Borbolla, Jose ;
Riemersma, Omar ;
Becerra, Henry ;
Rosell, Rafael .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) :1955-1959
[5]   Wood dust exposure and the association with lung cancer risk [J].
Barcenas, CH ;
Delclos, GL ;
El-Zein, R ;
Tortolero-Luna, G ;
Whitehead, LW ;
Spitz, MR .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2005, 47 (04) :349-357
[6]  
Burdick AD, 2003, CANCER RES, V63, P7825
[7]   Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life [J].
Cullen, MH ;
Billingham, LJ ;
Woodroffe, CM ;
Chetiyawardana, AD ;
Gower, NH ;
Joshi, R ;
Ferry, DR ;
Rudd, RM ;
Spiro, SG ;
Cook, JE ;
Trask, C ;
Bessell, E ;
Connolly, CK ;
Tobias, J ;
Souhami, RL .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3188-3194
[8]   Lung cancer pathogenesis associated with wood smoke exposure [J].
Delgado, J ;
Martinez, LM ;
Sánchez, TT ;
Ramirez, A ;
Iturria, C ;
González-Avila, G .
CHEST, 2005, 128 (01) :124-131
[9]  
DEVESA SS, 1991, CANCER EPIDEM BIOMAR, V1, P29
[10]   Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS) [J].
Fukuoka, Masahiro ;
Wu, Yi-Long ;
Thongprasert, Sumitra ;
Sunpaweravong, Patrapim ;
Leong, Swan-Swan ;
Sriuranpong, Virote ;
Chao, Tsu-Yi ;
Nakagawa, Kazuhiko ;
Chu, Da-Tong ;
Saijo, Nagahiro ;
Duffield, Emma L. ;
Rukazenkov, Yuri ;
Speake, Georgina ;
Jiang, Haiyi ;
Armour, Alison A. ;
To, Ka-Fai ;
Yang, James Chih-Hsin ;
Mok, Tony S. K. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) :2866-2874